Developer docs
API playgroundTry for free, no card

Search company profiles

Axonal

Full company profile

uuid00661ow

Namestring
Axonal
Legal namestring
Axonal.AI
Websiteurl
axonal.ai
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Axonal is a privately held, founder-led company building an agentic AI platform purpose-built for pharmaceutical commercialization. Its core primitive, the Decision Object, is a structured, persistent record that captures a commercial decision, the evidence that supported it, the alternatives weighed, and the rationale expected to hold up under later scrutiny. Specialized agents — Research, Analyst, Orchestration, Strategist+, and Validator+ — operate within structured workflows so that every output is explainable, citation-backed, and audit-ready, with the Validator+ agent enforcing regulatory and evidentiary standards continuously.

The product is sold as engagement-based Decision Packs rather than per-seat licenses: a Launch Decision Pack for pre-market brands (from $100K), a Market Decision Pack for in-market brands ($60K–$100K), a Rapid Response Pack for time-sensitive events ($15K–$30K per event), and an ongoing Decision Monitoring retainer ($15K–$30K/month, or $120K–$250K/year). The platform integrates with Veeva, Salesforce, and Medidata and is built to be HIPAA-aligned, SOC 2-aligned, and encrypted at rest with AES-256. The go-to-market is enterprise sales-led, founder-driven, with discovery routed through direct scheduling and a content engine anchored by the Axonal Perspectives blog and founder Larry Mickelberg's Launchcode book series.

Axonal targets global pharmaceutical companies, the cross-functional Commercial/Medical/Analytics teams inside them, emerging biotechs competing against larger players, and the launch/growth agencies that serve them. The company is small (1–10 employees), bootstrapped with no disclosed institutional funding, based in St. Petersburg, Florida, and was founded by Larry Mickelberg, whose background spans Deloitte, Publicis Health, and Havas. Recent validation includes MM+M's 2026 Power Partner designation and December 2025 inclusion in MM+M's roundup of AI pharma marketing tools that clients vouch actually work.

Short descriptiontext

Axonal is a privately held AI company building an agentic platform for pharmaceutical commercialization, anchored by its proprietary "Decision Object" primitive. It sells structured Decision Packs and ongoing Decision Monitoring retainers to global pharma, biotech, and their commercial teams to make durable, evidence-backed launch and market-access decisions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt. Petersburg, United States
HQ citystring
St. Petersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharma commercialization software, agentic AI platform, decision intelligence system, pharma launch strategy, commercial decision automation
Industry2 codes
PRIMARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAI
Channel & Trade Strategy (Gross-to-Net, Distribution Economics)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
NAICS code1 code
  • Marketing Consulting Services541613
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Commercialization Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Decision Pack Engagements
TypeProfessional Services
Description

Structured engagements delivering defined sets of Decision Objects in 4-6 weeks. Three tiers: Launch Decision Pack ($100K), Market Decision Pack ($60K-$100K), and Rapid Response Pack ($15K-$30K per event).

axonal.ai
2Decision Monitoring Retainer
TypeSubscription Recurring
Description

Monthly retainer for ongoing Decision Monitoring service that keeps Decision Objects current as markets evolve. Monthly retainer: $15K-$30K/month. Annual monitoring: $120K-$250K/year.

axonal.ai
3Pilot Programs
TypeProfessional Services
Description

Entry-point engagements structured around specific launch decisions or market share challenges, leading to broader ongoing engagements.

axonal.ai
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details4 tiers
1Launch Decision Pack - For brands preparing to enter the market with five Decision Objects covering positioning, messaging, competitive response, field prioritization, and market access strategy.
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Delivered in four to six weeks starting at $100K

axonal.ai
2Market Decision Pack - For in-market brands facing competitive pressure or evolving evidence with five Decision Objects.
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Delivered in four to six weeks from $60K to $100K

axonal.ai
3Rapid Response Pack - For teams facing specific market events requiring defensible decisions within 48 hours.
ModelUsage-basedBilling cadencePay-as-you-go
Notes

$15K to $30K per event, annual monitoring from $120K to $250K

axonal.ai
4Decision Monitoring - Ongoing intelligence layer that keeps Decision Objects current as markets evolve.
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly Retainer: $15K – $30K/month

axonal.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Axonal delivers an AI-native commercial operating system for pharmaceutical companies that replaces unstructured strategy decks with persistent, evidence-backed "Decision Objects." The company sells structured engagement packs (Launch Decision Pack for pre-launch brands, Market Decision Pack for in-market brands, and Rapid Response Pack for urgent market events) delivered in 4-6 weeks, plus ongoing Decision Monitoring retainers that keep decisions current as markets evolve. All offerings run on specialized agentic AI agents that produce citation-first, audit-ready outputs designed for regulated pharma environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • ~30% faster planning cycles
+7 more records
Product overview1 text field

Axonal.AI is an AI-native commercial operating system for pharmaceutical companies, built around a single core primitive: Decision Objects. The platform offers structured engagement packs—Launch Decision Pack (pre-launch strategy), Market Decision Pack (in-market optimization), and Rapid Response Pack (urgent events)—all supported by ongoing Decision Monitoring. The system operates through specialized AI agents (Research Agent, Analyst Agent, Orchestration Agent, Strategist+, and Validator+) that work within structured workflows to ensure every output is explainable, reviewable, and logged. Decision Objects capture the decision, evidence, reasoning, and outcomes, connecting directly to Actions that translate strategy into measurable execution steps.

Product and service5 records
1Axonal.AI Platform
CategoryPharmaceutical Commercialization Software
Description

AI-native commercial operating system for pharmaceutical companies that unifies product strategy into Decision Objects, powered by continuous market signals and designed to drive immediate action while preserving intent across teams and leadership changes. Built for regulated environments with HIPAA-aligned, SOC 2-aligned, and AES-256 encrypted architecture.

2Launch Decision Pack
CategoryPharma Launch Strategy Service
Description

Strategic entry engagement for brands preparing to enter the market. Delivers five Decision Objects covering positioning, messaging, competitive response, field prioritization, and market access strategy. Delivered in four to six weeks starting at $100K under multi-year contract terms.

3Market Decision Pack
CategoryPharma In-Market Optimization Service
Description

Market optimization engagement for in-market brands facing competitive pressure or evolving evidence. Delivers five Decision Objects covering competitive response, evidence strategy, narrative momentum, market risk, and signal monitoring. Delivered in four to six weeks from $60K to $100K under multi-year contract terms.

4Rapid Response Pack
CategoryPharma Critical Event Response Service
Description

Critical event engagement for teams facing specific market events such as competitor readouts, label updates, or congress moments, requiring a defensible decision inside 48 hours. Priced at $15K to $30K per event with annual monitoring from $120K to $250K.

5Decision Monitoring
CategoryPharma Decision Monitoring Subscription
Description

Ongoing retained intelligence layer that keeps Decision Objects current as markets evolve. All Decision Pack engagements convert to ongoing Decision Monitoring. Monthly retainer priced at $15K to $30K/month, with annual monitoring from $120K to $250K/year.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1ZS Associates
TypeBroad incumbent
Description

Large global management consulting and technology firm with deep pharma commercial analytics practice. Competes with Axonal by offering AI-driven sales, marketing, and analytics solutions to global pharma, though as part of a broader portfolio rather than agentic-AI-native platform.

TypeBroad incumbent
Description

Cloud software and data platform for life sciences with dominant pharma CRM position. Axonal integrates with Veeva, but Veeva's own AI roadmap (e.g., Vault AI) represents both a partnership vector and competitive threat in commercial decision support.

TypeBroad incumbent
Description

Global leader in life sciences commercial analytics, technology, and contract services. Provides data, AI, and consulting across pharma commercialization — Axonal competes for the same wallet share but lacks IQVIA's data assets and scale.

TypeBroad incumbent
Description

Data analytics and software platform for life sciences commercial operations, offering AI/ML-driven sales and marketing solutions. Comparable to Axonal in pharma commercialization focus but operates at significantly larger scale with broader consulting-plus-software model.

TypeBroad incumbent
Description

Digital commercialization partner for life sciences, combining technology platforms with commercial services for pharma launches. Overlaps with Axonal in launch strategy and market access execution, though Indegene operates globally with deeper service breadth.

TypeDirect peer
Description

AI-driven personalization platform for healthcare and life sciences engagement. Co-listed with Axonal in MM+M's AI pharma marketing tools roundup, with overlapping customer base in pharma commercial teams seeking AI-native engagement solutions.

TypeDirect peer
Description

Pharma commercial analytics consultancy delivering data-driven sales, marketing, and market access services. Comparable to Axonal's market access and launch strategy offerings, with overlap in advisory-plus-technology delivery to pharma clients.

TypeDirect peer
Description

AI-powered decision support platform for pharma commercial teams, providing real-time suggestions for sales and marketing. Direct comparable to Axonal's Decision Object concept — both target pharma field force optimization with intelligent workflow agents.

TypeDirect peer
Description

AI platform for pharma commercial and medical teams providing customer insights and engagement optimization. Named alongside Axonal in MM+M's AI pharma marketing tools roundup — direct comparable in AI-native pharma commercial intelligence.

TypeBroad incumbent
Description

Large global health-focused agency network offering pharma launch, creative, and digital promotion services. Founder Larry Mickelberg previously led at Publicis Health; competes with Axonal for pharma commercialization budgets through agency engagements.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Axonal

Pharmaceutical Commercialization Softwareaxonal.ai

Axonal is a privately held AI company building an agentic platform for pharmaceutical commercialization, anchored by its proprietary "Decision Object" primitive. It sells structured Decision Packs and ongoing Decision Monitoring retainers to global pharma, biotech, and their commercial teams to make durable, evidence-backed launch and market-access decisions.

What Axonal does

Axonal is a privately held, founder-led company building an agentic AI platform purpose-built for pharmaceutical commercialization. Its core primitive, the Decision Object, is a structured, persistent record that captures a commercial decision, the evidence that supported it, the alternatives weighed, and the rationale expected to hold up under later scrutiny. Specialized agents — Research, Analyst, Orchestration, Strategist+, and Validator+ — operate within structured workflows so that every output is explainable, citation-backed, and audit-ready, with the Validator+ agent enforcing regulatory and evidentiary standards continuously.

The product is sold as engagement-based Decision Packs rather than per-seat licenses: a Launch Decision Pack for pre-market brands (from $100K), a Market Decision Pack for in-market brands ($60K–$100K), a Rapid Response Pack for time-sensitive events ($15K–$30K per event), and an ongoing Decision Monitoring retainer ($15K–$30K/month, or $120K–$250K/year). The platform integrates with Veeva, Salesforce, and Medidata and is built to be HIPAA-aligned, SOC 2-aligned, and encrypted at rest with AES-256. The go-to-market is enterprise sales-led, founder-driven, with discovery routed through direct scheduling and a content engine anchored by the Axonal Perspectives blog and founder Larry Mickelberg's Launchcode book series.

Axonal targets global pharmaceutical companies, the cross-functional Commercial/Medical/Analytics teams inside them, emerging biotechs competing against larger players, and the launch/growth agencies that serve them. The company is small (1–10 employees), bootstrapped with no disclosed institutional funding, based in St. Petersburg, Florida, and was founded by Larry Mickelberg, whose background spans Deloitte, Publicis Health, and Havas. Recent validation includes MM+M's 2026 Power Partner designation and December 2025 inclusion in MM+M's roundup of AI pharma marketing tools that clients vouch actually work.

Axonal firmographics

Firmographics
Name
Axonal
Legal name
Axonal.AI
Website
https://axonal.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Axonal is a privately held AI company building an agentic platform for pharmaceutical commercialization, anchored by its proprietary "Decision Object" primitive. It sells structured Decision Packs and ongoing Decision Monitoring retainers to global pharma, biotech, and their commercial teams to make durable, evidence-backed launch and market-access decisions.
Ownership category
akta.pro rank

Axonal industry classification

Industry
Product category
Pharmaceutical Commercialization Software
NAICS
Marketing Consulting Services (541613)
SIC
Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAI
Channel & Trade Strategy (Gross-to-Net, Distribution Economics)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • Pharma commercialization software
  • Agentic AI platform
  • Decision intelligence system
  • Pharma launch strategy
  • Commercial decision automation

Where Axonal is headquartered

Location

Headquarters

HQ city
St. Petersburg
HQ country
United States
HQ region
North America

Markets served

Axonal business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Decision Pack Engagements: Structured engagements delivering defined sets of Decision Objects in 4-6 weeks. Three tiers: Launch Decision Pack ($100K), Market Decision Pack ($60K-$100K), and Rapid Response Pack ($15K-$30K per event).
  2. Decision Monitoring Retainer: Monthly retainer for ongoing Decision Monitoring service that keeps Decision Objects current as markets evolve. Monthly retainer: $15K-$30K/month. Annual monitoring: $120K-$250K/year.
  3. Pilot Programs: Entry-point engagements structured around specific launch decisions or market share challenges, leading to broader ongoing engagements.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractLaunch Decision Pack - For brands preparing to enter the market with five Decision Objects covering positioning, messaging, competitive response, field prioritization, and market access strategy.
One time/ perpetual licenseMulti-year contractMarket Decision Pack - For in-market brands facing competitive pressure or evolving evidence with five Decision Objects.
Usage-basedPay-as-you-goRapid Response Pack - For teams facing specific market events requiring defensible decisions within 48 hours.
SubscriptionMonthlyDecision Monitoring - Ongoing intelligence layer that keeps Decision Objects current as markets evolve.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Axonal product offering

Product offering

Core offering

Axonal delivers an AI-native commercial operating system for pharmaceutical companies that replaces unstructured strategy decks with persistent, evidence-backed "Decision Objects." The company sells structured engagement packs (Launch Decision Pack for pre-launch brands, Market Decision Pack for in-market brands, and Rapid Response Pack for urgent market events) delivered in 4-6 weeks, plus ongoing Decision Monitoring retainers that keep decisions current as markets evolve. All offerings run on specialized agentic AI agents that produce citation-first, audit-ready outputs designed for regulated pharma environments.

Product overview

Axonal.AI is an AI-native commercial operating system for pharmaceutical companies, built around a single core primitive: Decision Objects. The platform offers structured engagement packs—Launch Decision Pack (pre-launch strategy), Market Decision Pack (in-market optimization), and Rapid Response Pack (urgent events)—all supported by ongoing Decision Monitoring. The system operates through specialized AI agents (Research Agent, Analyst Agent, Orchestration Agent, Strategist+, and Validator+) that work within structured workflows to ensure every output is explainable, reviewable, and logged. Decision Objects capture the decision, evidence, reasoning, and outcomes, connecting directly to Actions that translate strategy into measurable execution steps.

Differentiator

Problem solved

Functional benefit

Products and services

  • Axonal.AI Platform AI-native commercial operating system for pharmaceutical companies that unifies product strategy into Decision Objects, powered by continuous market signals and designed to drive immediate action while preserving intent across teams and leadership changes. Built for regulated environments with HIPAA-aligned, SOC 2-aligned, and AES-256 encrypted architecture.
  • Launch Decision Pack Strategic entry engagement for brands preparing to enter the market. Delivers five Decision Objects covering positioning, messaging, competitive response, field prioritization, and market access strategy. Delivered in four to six weeks starting at $100K under multi-year contract terms.
  • Market Decision Pack Market optimization engagement for in-market brands facing competitive pressure or evolving evidence. Delivers five Decision Objects covering competitive response, evidence strategy, narrative momentum, market risk, and signal monitoring. Delivered in four to six weeks from $60K to $100K under multi-year contract terms.
  • Rapid Response Pack Critical event engagement for teams facing specific market events such as competitor readouts, label updates, or congress moments, requiring a defensible decision inside 48 hours. Priced at $15K to $30K per event with annual monitoring from $120K to $250K.
  • Decision Monitoring Ongoing retained intelligence layer that keeps Decision Objects current as markets evolve. All Decision Pack engagements convert to ongoing Decision Monitoring. Monthly retainer priced at $15K to $30K/month, with annual monitoring from $120K to $250K/year.

Quantifiable outcome

  • ~30% faster planning cycles
  • +7 more outcomes

Companies that use Axonal

Customer profile

Segments4 records

Ideal customer profiles4 records

Axonal technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature10 records

Axonal partnerships and signals

Strategic signal

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Axonal competitors and assessment

Company assessment

Broad incumbents

  • ZS Associates: Large global management consulting and technology firm with deep pharma commercial analytics practice. Competes with Axonal by offering AI-driven sales, marketing, and analytics solutions to global pharma, though as part of a broader portfolio rather than agentic-AI-native platform.
  • Veeva Systems: Cloud software and data platform for life sciences with dominant pharma CRM position. Axonal integrates with Veeva, but Veeva's own AI roadmap (e.g., Vault AI) represents both a partnership vector and competitive threat in commercial decision support.
  • IQVIA: Global leader in life sciences commercial analytics, technology, and contract services. Provides data, AI, and consulting across pharma commercialization — Axonal competes for the same wallet share but lacks IQVIA's data assets and scale.
  • Axtria: Data analytics and software platform for life sciences commercial operations, offering AI/ML-driven sales and marketing solutions. Comparable to Axonal in pharma commercialization focus but operates at significantly larger scale with broader consulting-plus-software model.
  • Indegene: Digital commercialization partner for life sciences, combining technology platforms with commercial services for pharma launches. Overlaps with Axonal in launch strategy and market access execution, though Indegene operates globally with deeper service breadth.
  • Publicis Health / Digitas Health: Large global health-focused agency network offering pharma launch, creative, and digital promotion services. Founder Larry Mickelberg previously led at Publicis Health; competes with Axonal for pharma commercialization budgets through agency engagements.

Direct peers

  • Lirio: AI-driven personalization platform for healthcare and life sciences engagement. Co-listed with Axonal in MM+M's AI pharma marketing tools roundup, with overlapping customer base in pharma commercial teams seeking AI-native engagement solutions.
  • Beghou Consulting: Pharma commercial analytics consultancy delivering data-driven sales, marketing, and market access services. Comparable to Axonal's market access and launch strategy offerings, with overlap in advisory-plus-technology delivery to pharma clients.
  • Aktana: AI-powered decision support platform for pharma commercial teams, providing real-time suggestions for sales and marketing. Direct comparable to Axonal's Decision Object concept — both target pharma field force optimization with intelligent workflow agents.
  • Odaia: AI platform for pharma commercial and medical teams providing customer insights and engagement optimization. Named alongside Axonal in MM+M's AI pharma marketing tools roundup — direct comparable in AI-native pharma commercial intelligence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Axonal social profiles

Digital presence

Axonal compliance and trust

Trust signal

Compliance2 records

Axonal financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Axonal leadership team

Management profile

Number of profiles

Profiles2 records

Axonal funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Axonal M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axonal

What does Axonal do?

Axonal delivers an AI-native commercial operating system for pharmaceutical companies that replaces unstructured strategy decks with persistent, evidence-backed "Decision Objects." The company sells structured engagement packs (Launch Decision Pack for pre-launch brands, Market Decision Pack for in-market brands, and Rapid Response Pack for urgent market events) delivered in 4-6 weeks, plus ongoing Decision Monitoring retainers that keep decisions current as markets evolve. All offerings run on specialized agentic AI agents that produce citation-first, audit-ready outputs designed for regulated pharma environments.

Is Axonal a public or private company?

Axonal is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Axonal founded?

Axonal was founded in 2024. It employs 1 to 10 people.

Where is Axonal based?

Axonal is headquartered in St. Petersburg, United States, in the North America region.

How does Axonal make money?

Three revenue lines are on record. Decision Pack Engagements are the primary driver. The others are decision Monitoring Retainer and pilot Programs.

Who are Axonal's main competitors?

Broad incumbents on record are ZS Associates, Veeva Systems, IQVIA, Axtria, Indegene and Publicis Health / Digitas Health. Direct peers are Lirio, Beghou Consulting, Aktana and Odaia.

Does Axonal have an API?

No public API is recorded for Axonal.

What industry is Axonal in?

Axonal's product category is Pharmaceutical Commercialization Software. Its primary akta.pro industry code is HLAIAKAA, Pricing & Contracting Strategy, with a secondary code of HLAIAKAI, Channel & Trade Strategy (Gross-to-Net, Distribution Economics). Its NAICS code is 541613 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals